229 related articles for article (PubMed ID: 33030706)
1. Procalcitonin in the Assessment of Ventilator Associated Pneumonia: A Systematic Review.
Alessandri F; Pugliese F; Angeletti S; Ciccozzi M; Russo A; Mastroianni CM; d'Ettorre G; Venditti M; Ceccarelli G
Adv Exp Med Biol; 2021; 1323():103-114. PubMed ID: 33030706
[TBL] [Abstract][Full Text] [Related]
2. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.
Pugh R; Grant C; Cooke RP; Dempsey G
Cochrane Database Syst Rev; 2011 Oct; (10):CD007577. PubMed ID: 21975771
[TBL] [Abstract][Full Text] [Related]
3. Clinical pulmonary infection score and a spot serum procalcitonin level to guide discontinuation of antibiotics in ventilator-associated pneumonia: a study in a single institution with high prevalence of nonfermentative gram-negative bacilli infection.
Wongsurakiat P; Tulatamakit S
Ther Adv Respir Dis; 2018; 12():1753466618760134. PubMed ID: 29506460
[TBL] [Abstract][Full Text] [Related]
4. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin as a biomarker for ventilator associated pneumonia in COVID-19 patients: Is it an useful stewardship tool?
Côrtes MF; de Almeida BL; Espinoza EPS; Campos AF; do Nascimento Moura ML; Salomão MC; Boszczowski I; Freire MP; de Carvalho LB; Paranhos-Baccalà G; Costa SF; Guimarães T
Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115344. PubMed ID: 34243136
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of procalcitonin in ventilator-associated pneumonia.
Corbacho Re MF; Rocchetti NS; Settecase CJ; Bagilet DH
Med Clin (Barc); 2019 Mar; 152(6):216-221. PubMed ID: 30154009
[TBL] [Abstract][Full Text] [Related]
7. Adhering to the procalcitonin algorithm allows antibiotic therapy to be shortened in patients with ventilator-associated pneumonia.
Beye F; Vigneron C; Dargent A; Prin S; Andreu P; Large A; Quenot JP; Bador J; Bruyere R; Charles PE
J Crit Care; 2019 Oct; 53():125-131. PubMed ID: 31228763
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of the point-of-care procalcitonin test for determining the antibiotic treatment duration in patients with ventilator-associated pneumonia in the intensive care unit: a randomised controlled trial.
Z Mazlan M; A H Ismail M; Ali S; Salmuna ZN; Wan Muhd Shukeri WF; Omar M
Anaesthesiol Intensive Ther; 2021; 53(3):207-214. PubMed ID: 34006044
[TBL] [Abstract][Full Text] [Related]
9. Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis.
Peng F; Chang W; Xie JF; Sun Q; Qiu HB; Yang Y
Int J Infect Dis; 2019 Aug; 85():158-166. PubMed ID: 31229612
[TBL] [Abstract][Full Text] [Related]
10. The use of inhaled antibiotic therapy in the treatment of ventilator-associated pneumonia and tracheobronchitis: a systematic review.
Russell CJ; Shiroishi MS; Siantz E; Wu BW; Patino CM
BMC Pulm Med; 2016 Mar; 16():40. PubMed ID: 26956371
[TBL] [Abstract][Full Text] [Related]
11. [Role of plasma procalcitonin in the diagnosis of ventilator-associated pneumonia: systematic review and metaanalysis].
Sotillo-Díaz JC; Bermejo-López E; García-Olivares P; Peral-Gutiérrez JA; Sancho-González M; Guerrero-Sanz JE
Med Intensiva; 2014; 38(6):337-46. PubMed ID: 24035696
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial.
Hellyer TP; Anderson NH; Parker J; Dark P; Van Den Broeck T; Singh S; McMullan R; Agus AM; Emerson LM; Blackwood B; Gossain S; Walsh TS; Perkins GD; Conway Morris A; McAuley DF; Simpson AJ
Trials; 2016 Jul; 17(1):318. PubMed ID: 27422026
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: diagnosis and treatment.
Muscedere J; Dodek P; Keenan S; Fowler R; Cook D; Heyland D;
J Crit Care; 2008 Mar; 23(1):138-47. PubMed ID: 18359431
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic efficacy of serum procalcitonin, C-reactive protein concentration and clinical pulmonary infection score in Ventilator-Associated Pneumonia.
Chen C; Yan M; Hu C; Lv X; Zhang H; Chen S
Med Sci (Paris); 2018 Oct; 34 Focus issue F1():26-32. PubMed ID: 30403171
[TBL] [Abstract][Full Text] [Related]
15. The methodological quality of guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia: A systematic review.
Ambaras Khan R; Aziz Z
J Clin Pharm Ther; 2018 Aug; 43(4):450-459. PubMed ID: 29722052
[TBL] [Abstract][Full Text] [Related]
16. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
Eachempati SR; Hydo LJ; Shou J; Barie PS
J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
[TBL] [Abstract][Full Text] [Related]
17. Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trials.
Weiss E; Essaied W; Adrie C; Zahar JR; Timsit JF
Crit Care; 2017 Jun; 21(1):162. PubMed ID: 28655326
[TBL] [Abstract][Full Text] [Related]
18. Classical and Molecular Techniques to Diagnose HAP/VAP.
Renaud C; Kollef MH
Semin Respir Crit Care Med; 2022 Apr; 43(2):219-228. PubMed ID: 35042263
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin-Guided Antibiotic Discontinuation and Mortality in Critically Ill Adults: A Systematic Review and Meta-analysis.
Pepper DJ; Sun J; Rhee C; Welsh J; Powers JH; Danner RL; Kadri SS
Chest; 2019 Jun; 155(6):1109-1118. PubMed ID: 30772386
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of procalcitonin-guided antibiotic therapy to shorten treatment duration in critically-ill patients with bloodstream infections: a systematic review and meta-analysis.
Robati Anaraki M; Nouri-Vaskeh M; Abdoli Oskouie S
Infez Med; 2020 Mar; 28(1):37-46. PubMed ID: 32172259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
